H S Overkleeft
Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma
Besse A, Besse L, Overkleeft H, Bader J, Kraus M, Morgan G, Weinhold N, Rasche L, Stolze S, Driessen C. Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma. Leukemia 2017; 32:391-401.
Jul 5, 2017Carfilzomib resistance due to ABCB1/MDR1 overexpression is overcome by nelfinavir and lopinavir in multiple myeloma
Jul 5, 2017Leukemia 2017; 32:391-401
Besse Andrej, Besse Lenka, Overkleeft H S, Bader J, Kraus Marianne, Morgan G J, Weinhold N, Rasche L, Stolze S C, Driessen Christoph
Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism
Soriano G, Florea B, Overkleeft H, den Dulk H, Everts B, Bader J, Meeuwenoord N, Besse A, Kraus M, Li N, Besse L, Driessen C. Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism. Leukemia 2016; 30:2198-2207.
Apr 27, 2016Proteasome inhibitor-adapted myeloma cells are largely independent from proteasome activity and show complex proteomic changes, in particular in redox and energy metabolism
Apr 27, 2016Leukemia 2016; 30:2198-2207
Soriano G P, Florea B I, Overkleeft H S, den Dulk H, Everts B, Bader J, Meeuwenoord N, Besse A, Kraus Marianne, Li N, Besse L, Driessen Christoph
Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells
Rückrich T, Kraus M, Gogel J, Beck A, Ovaa H, Verdoes M, Overkleeft H, Kalbacher H, Driessen C. Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009; 23:1098-105.
Jun 1, 2009Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells
Jun 1, 2009Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009; 23:1098-105
Rückrich T, Kraus Marianne, Gogel J, Beck A, Ovaa H, Verdoes M, Overkleeft H S, Kalbacher H, Driessen Christoph
The p41 isoform of invariant chain is a chaperone for cathepsin L
Lennon-Dumenil A, Ploegh H, Bikoff E, Peters P, Erickson A, Overkleeft H, Driessen C, Valentijn K, Roberts R, Wolf Bryant P. The p41 isoform of invariant chain is a chaperone for cathepsin L. The EMBO journal 2001; 20:4055-64.
Aug 1, 2001The p41 isoform of invariant chain is a chaperone for cathepsin L
Aug 1, 2001The EMBO journal 2001; 20:4055-64
Lennon-Dumenil A M, Ploegh H L, Bikoff E, Peters P J, Erickson A, Overkleeft H S, Driessen Christoph, Valentijn K, Roberts R A, Wolf Bryant P